Skip to main content
VIB PRISMA
Home
  • Home
  • Project
    • 1. Clinical characterization of two Flemish cohorts
    • 2. Calculation of AD risk scores
    • 3. Deep immunoprofiling
    • 4. Donor selection and creation of pluripotent stem cells
    • 5. In vitro characterization
    • 6. In vivo characterization
    • 7. Linking of research data
    • 8. Exploring the usefulness of PRS in clinical practice
  • What's next?
  • Partners
  • Contact
  • Home
  • Project
    • 1. Clinical characterization of two Flemish cohorts
    • 2. Calculation of AD risk scores
    • 3. Deep immunoprofiling
    • 4. Donor selection and creation of pluripotent stem cells
    • 5. In vitro characterization
    • 6. In vivo characterization
    • 7. Linking of research data
    • 8. Exploring the usefulness of PRS in clinical practice
  • What's next?
  • Partners
  • Contact
  • Log in

404

  • Discover PRISMA

    • Home
    • PRISMA
    • What's next?
    • Partners
  • Partners

    • VIB
    • KU Leuven
    • reMYND
    • imec
    • ONTOFORCE
    • HICT
  • © VIB
  • Disclaimer
  • Cookies
  • Cookie policy
  • Privacy
Administrator login Cookie preferences